Outcomes of ventricular tachycardia substrate ablation facilitated by preprocedural imaging scar characterization. A prospective multicenter registry

• Published in: Europace (London, England) Vol. 25; no. Supplement_1
• Main Authors: Penela, D, Soto-Iglesias, D, Fernandez-Armenta, J, Vatasescu, R, Zucchelli, G, Falasconi, G, Marti-Almor, J, Franco, P, Alderete, J, Ordonez, A, Viveros, D, Bellido, A, Francia, P, Huguet, M, Berruezo, A
• Format: Journal Article
• Language: English
• Published: US Oxford University Press 24.05.2023
• ISSN: 1099-5129; 1532-2092
• DOI: 10.1093/europace/euad122.329

Abstract Funding Acknowledgements Type of funding sources: None. Background Catheter ablation is a recommended therapy for patients with ventricular tachycardia (VT). However, recurrences rate in non-ischemic cardiomyopathy (NICM) patients remains high. Objectives To analyze outcomes of VT substrate ablation facilitated by the integration into the navigator system of the preprocedural image scar characterization in both, patients with ischemic cardiomyopathy (ICM) cand NICM. Methods One hundred and sixty-five consecutive patients with structural heart disease undergoing scar related left-side VT ablation were included in a prospective European multicenter (5 centers) registry. Pixel signal intensity (PSI) maps from the late gadolinium enhancement-CMR (LGE-CMR) and/or the multi-detector cardiac tomography (MDCT) were imported into the navigator system. Ablation approach (e.g. endo vs epicardial; left vs right side) was based in the scar distribution aiming to eliminate the entire arrhythmogenic substrate. Mapping and ablation were focused in the scar areas. In all patients Scar dechanneling was the substrate ablation technique used. Results 165 [153 (93%) men, 66+12 y.o, 117 (71%) with ischemic heart disease] patients were included. Pre-procedure CMR was performed in 65 (39%), MDCT in 12 (7%) and both in 88 (53%) patients. VT induction protocol was negative after substrate ablation in 121 (73%) patients, completing the procedure in stable sinus rhythm. Procedure related complication rate was 5.5%. Arter a mean follow-up of 18+19 months, overall survival was 91% and 44 (27%) patients had VT recurrences. There was no difference in VT-free survival in ischemic vs non-ischemic patients (Log rank:0.9), as Figure 1 shows. Conclusions A strategy of VT substrate ablation facilitated by the integration into the navigator system of the preprocedural image scar characterization with the aim of eliminate the entire arrhythmogenic substrate results in a low recurrence rate. This approach minimizes the gap in VT-free survival after ablation in patients with ICM and NICM.